Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Randal K, Wada"'
Autor:
Giselle L. Saulnier Sholler, Genevieve Bergendahl, Elizabeth C. Lewis, Jacqueline Kraveka, William Ferguson, Abhinav B. Nagulapally, Karl Dykema, Valerie I. Brown, Michael S. Isakoff, Joseph Junewick, Deanna Mitchell, Jawhar Rawwas, William Roberts, Don Eslin, Javier Oesterheld, Randal K. Wada, Devang Pastakia, Virginia Harrod, Kevin Ginn, Raya Saab, Kevin Bielamowicz, Jason Glover, Eugenia Chang, Gina K. Hanna, Daniel Enriquez, Tyler Izatt, Rebecca F. Halperin, Abigail Moore, Sara A. Byron, William P. D. Hendricks, Jeffrey M. Trent
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-18 (2024)
Abstract Background Children with relapsed central nervous system (CNS tumors), neuroblastoma, sarcomas, and other rare solid tumors face poor outcomes. This prospective clinical trial examined the feasibility of combining genomic and transcriptomic
Externí odkaz:
https://doaj.org/article/aabaaa1d731d43219ab2b7d7fb61c753
Autor:
Jacqueline M. Kraveka, Elizabeth C. Lewis, Genevieve Bergendahl, William Ferguson, Javier Oesterheld, Elizabeth Kim, Abhinav B. Nagulapally, Karl J. Dykema, Valerie I. Brown, William D. Roberts, Deanna Mitchell, Don Eslin, Derek Hanson, Michael S. Isakoff, Randal K. Wada, Virginia L. Harrod, Jawhar Rawwas, Gina Hanna, William P. D. Hendricks, Sara A. Byron, Matija Snuderl, Jonathan Serrano, Jeffrey M. Trent, Giselle L. Saulnier Sholler
Publikováno v:
Cancer Reports, Vol 5, Iss 11, Pp n/a-n/a (2022)
Abstract Background Survival for patients with high‐risk neuroblastoma (HRNB) remains poor despite aggressive multimodal therapies. Aims To study the feasibility and safety of incorporating a genomic‐based targeted agent to induction therapy for
Externí odkaz:
https://doaj.org/article/ac998ae6e1bf48a5a89903e3790cf17a
Autor:
Randal K. Wada, Lorrie Wong, Anke Flohr, Robin G. Arndt, Dana K. Ing, Joanne R. Loos, Lori Kaneshige, Kimm Teruya, Kal Peterman, Cheryl L. Albright, Kamal Masaki
Publikováno v:
Clinical Simulation in Nursing. 78:27-33
Autor:
Don Eslin, Peter E. Zage, Genevieve Bergendahl, Elizabeth Lewis, William Roberts, Jacqueline Kraveka, Deanna Mitchell, Michael S. Isakoff, Jawhar Rawwas, Randal K. Wada, Mark Fluchel, Valerie I. Brown, Kevin Ginn, Timothy Higgins, Abhinav BeeravallyNagulapally, Karl Dykema, Gina Hanna, William Ferguson, Giselle L. Saulnier Sholler
Publikováno v:
International Journal of Cancer.
Autor:
Jeffrey M. Trent, Giselle L. Saulnier Sholler, Javed Khan, Rebecca F. Halperin, Jonathan J. Keats, Szabolcs Szelinger, Bryce Turner, Austin Christofferson, Faith Cisneros, Apurva M. Hegde, Daniel Enriquez, Tyler Izatt, Sara Nasser, Alison Roos, Hue V. Reardon, Xinyu Wen, Jun S. Wei, Hsien-Chao Chou, Jeffrey Bond, Karl Dykema, Elizabeth VanSickle, Genevieve Bergendahl, Virginia L. Harrod, Peter E. Zage, Kathleen Neville, Jawhar Rawwas, Randal K. Wada, Javier E. Oesterheld, Michael S. Isakoff, William Roberts, Albert Cornelius, Deanna Mitchell, Don E. Eslin, Valerie I. Brown, William S. Ferguson, Jacqueline M. Kraveka, Abhinav B. Nagulapally, William P.D. Hendricks, Sara A. Byron
Most Variably Expressed Genes in Relapsed and Refractory Childhood Solid Tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e630aa53ee1d125874e781fa7689359
https://doi.org/10.1158/0008-5472.22431262.v1
https://doi.org/10.1158/0008-5472.22431262.v1
Autor:
Jeffrey M. Trent, Giselle L. Saulnier Sholler, Javed Khan, Rebecca F. Halperin, Jonathan J. Keats, Szabolcs Szelinger, Bryce Turner, Austin Christofferson, Faith Cisneros, Apurva M. Hegde, Daniel Enriquez, Tyler Izatt, Sara Nasser, Alison Roos, Hue V. Reardon, Xinyu Wen, Jun S. Wei, Hsien-Chao Chou, Jeffrey Bond, Karl Dykema, Elizabeth VanSickle, Genevieve Bergendahl, Virginia L. Harrod, Peter E. Zage, Kathleen Neville, Jawhar Rawwas, Randal K. Wada, Javier E. Oesterheld, Michael S. Isakoff, William Roberts, Albert Cornelius, Deanna Mitchell, Don E. Eslin, Valerie I. Brown, William S. Ferguson, Jacqueline M. Kraveka, Abhinav B. Nagulapally, William P.D. Hendricks, Sara A. Byron
Table S1. Extended Cohort Annotations. Table S2. Mutational Signatures. Table S3. GISTIC Copy Number Analysis. Table S4. Somatic Variants in Relapsed/Refractory Childhood Solid Tumors (n=184 Patients with T/N WES). Table S5. Clinvar Pathogenic and Li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1e39ae7fd69f2b814d3c10f93f7f3e1
https://doi.org/10.1158/0008-5472.22431247.v1
https://doi.org/10.1158/0008-5472.22431247.v1
Autor:
Jeffrey M. Trent, Giselle L. Saulnier Sholler, Javed Khan, Rebecca F. Halperin, Jonathan J. Keats, Szabolcs Szelinger, Bryce Turner, Austin Christofferson, Faith Cisneros, Apurva M. Hegde, Daniel Enriquez, Tyler Izatt, Sara Nasser, Alison Roos, Hue V. Reardon, Xinyu Wen, Jun S. Wei, Hsien-Chao Chou, Jeffrey Bond, Karl Dykema, Elizabeth VanSickle, Genevieve Bergendahl, Virginia L. Harrod, Peter E. Zage, Kathleen Neville, Jawhar Rawwas, Randal K. Wada, Javier E. Oesterheld, Michael S. Isakoff, William Roberts, Albert Cornelius, Deanna Mitchell, Don E. Eslin, Valerie I. Brown, William S. Ferguson, Jacqueline M. Kraveka, Abhinav B. Nagulapally, William P.D. Hendricks, Sara A. Byron
Children with treatment-refractory or relapsed (R/R) tumors face poor prognoses. As the genomic underpinnings driving R/R disease are not well defined, we describe here the genomic and transcriptomic landscapes of R/R solid tumors from 202 patients e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f3927cdafa8ff7060a5a484ff93c70c
https://doi.org/10.1158/0008-5472.c.6513853.v1
https://doi.org/10.1158/0008-5472.c.6513853.v1
Autor:
Giselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, Robert B MacArthur, Alyssa VanderWerff, Takamaru Ashikaga, Jeffrey P Bond, William Ferguson, William Roberts, Randal K Wada, Don Eslin, Jacqueline M Kraveka, Joel Kaplan, Deanna Mitchell, Nehal S Parikh, Kathleen Neville, Leonard Sender, Timothy Higgins, Masao Kawakita, Kyoko Hiramatsu, Shun-Suke Moriya, André S Bachmann
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0127246 (2015)
Neuroblastoma (NB) is the most common cancer in infancy and most frequent cause of death from extracranial solid tumors in children. Ornithine decarboxylase (ODC) expression is an independent indicator of poor prognosis in NB patients. This study inv
Externí odkaz:
https://doaj.org/article/13b951d6c59f4d47b37591a58fc4d1c9
Autor:
Faith Cisneros, Austin Christofferson, Deanna Mitchell, Jawhar Rawwas, Don E Eslin, Randal K. Wada, Javier Oesterheld, Genevieve Bergendahl, Xinyu Wen, Jun S. Wei, Hue V. Reardon, Tyler Izatt, Jeffrey M. Trent, William Roberts, William P.D. Hendricks, Virginia L Harrod, Karl Dykema, Sara Nasser, Sara A. Byron, Elizabeth VanSickle, Bryce Turner, Jacqueline M. Kraveka, Peter E. Zage, Alison Roos, Apurva M. Hegde, Valerie I. Brown, Kathleen A. Neville, Albert Cornelius, Jonathan J Keats, Szabolcs Szelinger, Rebecca F. Halperin, Michael S. Isakoff, William S. Ferguson, Daniel Enriquez, Javed Khan, Abhinav Nagulapally, Jeffrey P. Bond, Hsien-Chao Chou, Giselle Saulnier Sholler
Publikováno v:
Cancer Res
Cancer research, vol 81, iss 23
Cancer research, vol 81, iss 23
Children with treatment-refractory or relapsed (R/R) tumors face poor prognoses. As the genomic underpinnings driving R/R disease are not well defined, we describe here the genomic and transcriptomic landscapes of R/R solid tumors from 202 patients e
Publikováno v:
Pediatric bloodcancerREFERENCES. 68(2)